|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
OPENING REMARKS |
|
Plenary Session 1: |
THE THREE LEGACIES; WHITE, PEDERSEN, FREINKEL |
PERSISTING PERINATAL AND MATERNAL PROBLEMS IN DIABETES |
GLYCEMIC THRESHOLDS IN REAL LIFE |
FETAL SURVEILLANCE IN THE PREGESTATIONAL DIABETIC PREGNANCY |
Coffee Break, Exhibition and Poster Viewing |
| Plenary Session 2: GDM |
GDM FROM PHYSIOLOGY TO PATHOLOGY |
GDM – IS IT REALLY A DISEASE? |
THE HYPERGLYCEMIA & ADVERSE PREGNANCY OUTCOME (HAPO) STUDY: ADDRESSING THE CONTROVERSIES ABOUT THE DETECTION AND DIAGNOSIS OF GDM |
ARE WE GOOD ENOUGH TO MANAGE GDM? |
Lunch Break, Exhibition and Poster Viewing |
Novo Nordisk Session |
MANAGING DIABETIC PREGNANCY; DO WE NEED A CHANGE? |
INSULIN ASPART IN PREGNANCY; TYPE 1 – PRESENTATION OF ANA-1474 RESULTS |
INSULIN ASPART IN PREGNANCY; GDM – ANA-2067 RESULTS |
INSULIN ASPART IN TYPE 2 |
INSULIN DETEMIR IN PREGNANCY; PRESENTATION OF STUDY PROTOCOL |
CLOSING REMARKS |
Coffee Break, Exhibition and Poster Viewing |
Plenary Session 3: DIABETIC PREGNANCY AROUND THE WORLD |
CHINA |
JAPAN |
DIABETES AND PREGNANCY IN THE ADVANCING NATIONS - INDIA |
THAILAND |
| TURKEY Taner Damci |
THE ROLE OF INTERNATIONAL ORGANIZATIONS – IDF |
THE ROLE OF FIGO IN THE REDUCTION OF MATERNAL MORTALITY |
Welcome Reception |
FRIDAY, MARCH 30, 2007 |
ˆTop |
Plenary Session 4: ULTRASONOGRAPHY |
IS THERE A ROLE FOR DOPPLER/FLOW EVALUATION IN DIABETIC MANAGEMENT? |
ARE ALL CONGENITAL ANOMALIES DETECTABLE? |
CAN WE IMPROVE FETAL WEIGHT ESTIMATION? |
MONITORING THE FETUS OF DIABETIC MOTHER: IS THERE ANY ROLE OF BIOPHYSICAL PROFILE? |
Coffee Break, Exhibition and Poster Viewing |
Plenary Session 5: |
GDM - OBESITY/METABOLIC SYNDROME AND PREGNANCY OUTCOME |
METABOLIC SYNDROME VERSUS GDM IN PREGNANCY |
|
OBESITY VERSUS HYPERGLYCEMIA; GDM OUTCOMES |
|
OBESITY IN GDM |
|
PREGNANCY AND LOSING WEIGHT – ARE THEY MUTUALLY EXCLUSIVE? |
|
WHAT PREVAILS IN PREGNANCY OUTCOME, GDM OR OBESITY? |
|
Lunch, Exhibition and Poster Viewing |
|
Plenary Session 6: |
LONG TERM CONSEQUENCES – MATERNAL AND FETAL |
THE OFFSPRING; SHORT AND LONG TERM OUTCOME |
|
IS ABNORMAL GLUCOSE TOLERANCE IN PREGNANCY AN EARLY MARKER OF THE METABOLIC SYNDROME? |
|
PERINATAL OUTCOME IN TYPE 2 DM |
|
PERINATAL MORTALITY IN DIABETIC PREGNANCY; THE IMPACT OF METABOLIC CONTROL |
|
FETO-NEONATAL METABOLIC SYNDROME |
|
Coffee Break, Exhibition and Poster Viewing |
|
Plenary Session 7: DELIVERY IN DIABETIC PREGNANCY |
IS THERE AN EFW CUT OFF FOR VAGINAL DELIVERY? |
SHOLDER DYSTOCIA – PREVENTABLE PHENOMENA? |
LUNG MATURITY TESTING IN DIABETIC PREGNANCY; THE VANISHING CONCEPT? |
Debate: CS FOR ALL DIABETIC PREGNANCIES |
Gala Dinner (Optional) |
SATURDAY, MARCH 31, 2007 |
ˆTop |
Plenary Session 8: NEW TECHNOLOGIES |
THE IMPLICATION OF CGMS ON CLINICAL PRACTICE? |
CSII IN PREGNANCY |
APPROACHING THE CLOSED LOOP – CGMS + CSII IN PREGNANCY |
CLOSING THE LOOP – THE CLINICAL EXPERIENCE |
| eHEALTH
Linda Harnevo, Israel |
CONTINUOUS SIMULTANEOUS MATERNAL GLUCOSE AND FETAL HEART RATE MONITORING |
Coffee Break, Exhibition and Poster Viewing |
Plenary Session 9: BASIC SCIENCE AND THE PLACENTA |
DIABETES INDUCES INFLAMMATORY CHANGES IN THE PLACENTA |
THE FETO-PLACENTAL INSULIN-IGF SYSTEM IN DIABETES |
PROINFLAMMATORY MARKERS IN EMBRYOS AND PLACENTA FROM DIABETIC PREGNANCIES |
CONGENITAL MALFORMATIONS IN DIABETIC PREGNANCY |
Lunch, Exhibition and Poster Viewing |
Plenary Session 10: MEDICAL COMPLICATIONS AND DIABETIC PREGNANCY |
THE IMPACT OF FETO-MATERNAL CELL AND DNA TRAFFIC FOR MATERNAL DISEASES |
THE ASSOCIATION BETWEEN INSULIN RESISTANCE AND PET |
IS PET PREVENTABLE IN DIABETIC PREGNANCY? |
PREVIOUS GESTATIONAL DIABETES AND METABOLIC SYNDROME? |
Closing Session: PHARMACOLOGICAL TREATMENT IN GDM |
Discussion |
CLOSING COMMENTS |
